CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced that it will present at the Needham Virtual Healthcare Conference on Wednesday, April 15, 2020, at 11:20 a.m. ET. A live webcast of the presentation will be available on the Company’s website at An audio archive will be [...]